Actualités sur le dépistage et la prévention des infections à VPH dans le cadre des cancers du col utérin [Current developments in uterine cervical carcinoma prevention and screening]

Details

Ressource 1Download: Rev Med Suis_2015_current developt in uterinepdf.pdf (1160.72 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_EDA6F25440BD
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Title
Actualités sur le dépistage et la prévention des infections à VPH dans le cadre des cancers du col utérin [Current developments in uterine cervical carcinoma prevention and screening]
Journal
Revue medicale suisse
Author(s)
Mathevet P., Jacot-Guillarmod M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
28/10/2015
Peer-reviewed
Oui
Volume
11
Number
492
Pages
1999-2003
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
The causality between the HPV infection and the carcinoma of the uterine cervix is demonstrated. The benefits of the prophylactic HPV vaccine are emerging in the general population. This vaccine has no evident general side effect. So it is proposed for young women and young men. The commercialization of a nonavalent vaccine will increase its preventive activity. Already, international societies recommend using the HPV test for cervical carcinoma screening in replacement of the cytology in women more than 30-35 years old. In case of negative test, the interval between screenings can be increase until 5 years. In case of positive test, the cervical cytology is used for the triage, but other tests are under development. Due to the vaccine efficacy, the future modalities and the cost/benefits ratio of the screening should be questioned.

Keywords
Adult, Female, Humans, Male, Mass Screening/economics, Mass Screening/methods, Papillomavirus Infections/complications, Papillomavirus Infections/diagnosis, Papillomavirus Infections/prevention & control, Papillomavirus Vaccines/administration & dosage, Uterine Cervical Neoplasms/diagnosis, Uterine Cervical Neoplasms/prevention & control, Uterine Cervical Neoplasms/virology
Pubmed
Create date
15/11/2017 16:34
Last modification date
20/08/2019 17:15
Usage data